Archives

img-01

Asia: The Global Drug Inspection Challenge

In January 2013, FDA inspectors made public a warning letter issued to a Taiwanese chemical manufacturer in December. Citing serious violations of recordkeeping and in-process testing, the letter said that Beanne Chemical facility had failed on multiple counts to validate its manufacturing... Read More

img-01

Opportunities in Asias Expanding Self-Care Market

Important players in the consumer healthcare industry have been pushing Asian regulators to increase access to self-care products and loosen the rules surrounding their advertising and sales. As populations from Japan to China suffer increasingly from chronic and age related diseases, industry... Read More

img-01

Intelligent Access to China’s Pharmaceutical Market

As profit margins in Western markets plummet, multinational pharmaceutical companies are targeting emerging markets like China for future revenue growth. China is set to become the worlds second-largest pharmaceutical market by 2016. It currently ranks third, with an estimated value of $70... Read More